Invest in

Repeal Obamacare

32.2%
1.1%
0.8%

Affordable Care May Not Be So Affordable

Not everybody feels good about Obamacare. It’s actually called the Patient Protection and Affordable Care Act of 2010 and was upheld by the Supreme Court in June 2012. Since then, the enactment of new sales taxes, funding cuts, and lower reimbursement rates it contains have had a significant impact on the healthcare system.[1] For example, Obamacare imposes a 2.3% excise tax on the sales of medical devices, which industry lobbyist argue could have an adverse effect on job creation, investment in new research and cut up to half of the profits for medical device companies.[2] Not surprisingly, $150 million has been spent by these companies since 2008[2] to repeal the tax while their stock prices have underperformed the overall healthcare sector and the broader S&P 500 by a wide margin. [3] As the implementation of Obamacare begins on October 1st, 2013, Republicans are committed to repealing parts of bill which they believe negatively impact the healthcare system. See more
32.2%
1.1%
0.8%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Repeal Obamacare Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
39.3% Assisted Living 21.1%
14.1% National HealthCare Corporation NHC 22.6%
6.5% The Ensign Group Inc. ENSG 3.3%
6.3% Almost Family Inc. AFAM 30.0%
3.2% Addus HomeCare Corporation ADUS 48.3%
2.5% Civitas Solutions Inc. CIVI 7.8%
2.4% Amedisys Inc. AMED 28.7%
2.2% LHC Group Inc. LHCG 35.3%
2.1% Capital Senior Living Corp. CSU 11.3%
30.3% Medical Devices 71.7%
8.8% Globus Medical Inc. Class A GMED 17.0%
6.4% NuVasive Inc. NUVA 87.3%
5.1% NxStage Medical Inc. NXTM 101.9%
4.3% Insulet Corporation PODD 57.8%
3.2% ABIOMED Inc. ABMD 47.5%
1.4% Exact Sciences Corporation EXAS 205.1%
1.2% Cardiovascular Systems Inc. CSII 219.8%
30.3% Diagnostics 31.8%
20.0% Quest Diagnostics Incorporated DGX 50.6%
5.3% Myriad Genetics Inc. MYGN 51.0%
3.1% NeoGenomics Inc. NEO 31.0%
1.0% Veracyte Inc. VCYT 22.3%
0.9% GenMark Diagnostics Inc. GNMK 114.3%

Quotes delayed 15 mins. Currently Feb 19, 2017 1:40:44 PM. Fields are marked with -- when data is unavailable.